Endothelial specific Jag1 overexpression led to significantly accelerated growth of subcutaneous tumors, from day eleven after injection, with a final tumor volume more than two-fold larger (1370 mm3) than that of the respective controls (570 mm3) (Figure 1A). Here, JAG1 is linked to neoplasm.